Higgins, King, Kilmer, Fitzpatrick to serve as co-chairs of House Cancer Caucus

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Brian Higgins
Peter King
Peter King
Brian Fitzpatrick

Leading the House of Representatives Cancer Caucus are co-chairs House members Brian Higgins (D-NY), Peter King (R-NY), Derek Kilmer (D-WA), and Brian Fitzpatrick (R-PA).

Brian is a member of the House Budget Committee and the Committee on Ways & Means including its subcommittee on Health. His district includes Roswell Park Comprehensive Cancer Center.

Higgins is a founding member and co-chair of the NIH Caucus, a member of the Childhood Cancer Caucus, and an original sponsor of the Cancer Drug Parity Act.

“As a co-chair of the Cancer Caucus, I will continue to advocate for increased investment in cancer research,” King said in a statement. “It is essential we continue to fight hard and provide researchers with the necessary resources.”

“The Cancer Caucus is a leading voice on cancer research and funding in Congress,” Fitzpatrick said in a statement. “Cancer is indiscriminate, afflicting millions of Americans each year from all walks of life.”

YOU MAY BE INTERESTED IN

The rapid adoption of glucagon-like peptide-1 receptor agonists (GLP-1RAs), particularly for weight management, represents one of the most significant shifts in metabolic medicine in decades. With millions of people now using medications such as semaglutide and tirzepatide, we are witnessing a fundamental alteration in patient physiology that extends far beyond glucose control and weight loss. As these drugs approach 10% population penetrance in some demographics, the oncology community faces an urgent question: How will this metabolic transformation reshape cancer care?

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login